Trials / Completed
CompletedNCT02687139
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
In this study the investigators aim to evaluate diagnostic utility of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL PET/CT in patients with renal cell carcinoma (RCC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-DCFPyL | |
| PROCEDURE | PET/CT | Positron Emission Tomography - Computed Tomography (PET/CT) |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2016-02-22
- Last updated
- 2020-04-29
- Results posted
- 2020-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02687139. Inclusion in this directory is not an endorsement.